<DOC>
	<DOCNO>NCT01169792</DOCNO>
	<brief_summary>The genetic polymorphism cytochrome P450 may influence metabolism tamoxifen . The investigator want - evaluate frequency incidence genetic polymorphism cytochrome P450 subfamily ( CYP2D6 , CYP3A4/5 CYP2C19 ) breast cancer patient , - analyze association genetic polymorphism cytochrome P450 subfamily clinical outcome breast cancer patient treat adjuvant tamoxifen therapy .</brief_summary>
	<brief_title>Study Cytochrome P450 Polymorphisms ( CYP2D6 , CYP3A4/5 CYP2C19 ) Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<mesh_term>Antineoplastic Agents , Hormonal</mesh_term>
	<criteria>age â‰¥ 18 year Breast cancer patient underwent surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Tamoxifen</keyword>
	<keyword>Cytochrome P-450 CYP2D6</keyword>
	<keyword>Polymorphism</keyword>
	<keyword>Single nucleotide</keyword>
	<keyword>Antineoplastic Agents , Hormonal</keyword>
</DOC>